The evidence on child and maternal outcomes after exposure to classic psychedelics during pregnancy is very sparse and of very low certainty. A systematic review of 42 studies, mostly case reports from high-income countries, found that LSD was the most commonly reported substance. Outcomes reported included spontaneous abortions (2 studies), stillbirth (1 study), neonatal mortality (16 studies), preterm birth (17 studies), birthweight (15 studies), and congenital malformations (26 studies). No maternal deaths were reported. Because of small sample sizes and varied study designs, no meta-analysis was possible. The authors conclude that methodologically rigorous research on psychedelic use during pregnancy is urgently needed.
In a large twin study using the Swedish Twin Registry, people who reported using psychedelics had lower odds of having a history of migraine. Among identical twins, the twin who used psychedelics was less likely to have migraine than their co-twin who did not. The association was significant in males but not in females. These results suggest a possible link between psychedelic use and reduced migraine likelihood, with sex differences that need further study.